(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.40%90.99B | 0.19%58.31B | 9.58%30.74B | 4.77%122.4B | 3.86%90.62B | 4.68%58.2B | -5.88%28.05B | 12.76%116.83B | 15.86%87.25B | 9.99%55.6B |
Operating income | 0.40%90.99B | 0.19%58.31B | 9.58%30.74B | 4.77%122.4B | 3.86%90.62B | 4.68%58.2B | -5.88%28.05B | 12.76%116.83B | 15.86%87.25B | 9.99%55.6B |
Operating expenses | 3.97%-77.66B | -1.74%-26.62B | -0.64%-80.87B | 4.38%-26.16B | -16.91%-80.35B | |||||
Gross profit | 36.71%13.33B | 118.24%4.12B | 41.36%9.75B | -22.74%1.89B | 4.89%6.9B | |||||
Selling expenses | 2.25%-87.89M | ---- | -4.73%-21.67M | ---- | -4.92%-89.92M | ---- | 38.71%-20.69M | ---- | -103.51%-85.7M | ---- |
Administrative expenses | -4.75%-1.57B | ---- | -4.70%-469.21M | ---- | 2.30%-1.5B | ---- | -3.01%-448.14M | ---- | -3.05%-1.53B | ---- |
Research and development expenses | 7.30%-5.9M | ---- | 53.85%-546K | ---- | 21.88%-6.37M | ---- | -5.44%-1.18M | ---- | -787.80%-8.15M | ---- |
Profit from asset sales | -100.80%-145K | ---- | 380.95%59K | ---- | 630.63%18.07M | ---- | 99.69%-21K | ---- | -109.83%-3.41M | ---- |
Employee expense | ---- | -1.81%-3.62B | ---- | -23.54%-11.18B | ---- | 1.84%-3.56B | ---- | -0.96%-9.05B | ---- | -2.75%-3.62B |
Depreciation and amortization | ---- | -4.82%-7.13B | ---- | -3.12%-13.65B | ---- | -5.40%-6.8B | ---- | 0.40%-13.24B | ---- | 5.48%-6.45B |
Revaluation surplus | -135.41%-22.47M | ---- | ---- | ---- | -69.80%63.45M | ---- | ---- | ---- | 54.87%210.12M | ---- |
-Changes in the fair value of other assets | -135.41%-22.47M | ---- | ---- | ---- | -69.80%63.45M | ---- | ---- | ---- | 54.87%210.12M | ---- |
Impairment and provision | -96,575.40%-964.75M | ---- | ---- | ---- | 259.49%1M | ---- | ---- | ---- | 99.95%-627K | ---- |
-Other impairment is provision | -96,575.40%-964.75M | ---- | ---- | ---- | 259.49%1M | ---- | ---- | ---- | 99.95%-627K | ---- |
Special items of operating profit | 13.51%2.41B | 5.96%-40.46B | -70.19%175.37M | 2.09%-88.32B | 20.52%2.12B | -5.47%-43.02B | 442.00%588.36M | -2.90%-90.21B | -26.39%1.76B | -18.53%-40.79B |
Operating profit | 28.02%12.11B | 52.32%6.47B | 103.76%3.47B | 162.05%8.02B | 50.32%9.46B | 3.07%4.25B | 13.56%1.71B | 140.49%3.06B | 14.47%6.29B | -19.76%4.12B |
Financing income | ---- | -41.59%28.02M | ---- | 5.04%97.79M | ---- | 4.59%47.97M | ---- | 12.92%93.1M | ---- | 69.45%45.87M |
Financing cost | 7.40%-4.02B | 11.82%-2.65B | 10.44%-1.36B | 14.07%-5.77B | 13.33%-4.34B | 12.12%-3B | 11.28%-1.52B | -1.34%-6.71B | -2.98%-5.01B | -4.42%-3.42B |
Share of profits of associates | ---- | -8.32%1.36B | ---- | 6.77%2.32B | ---- | 57.69%1.48B | ---- | -15.48%2.17B | ---- | -2.62%941.15M |
Share of profit from joint venture company | ---- | 109.46%5.21M | ---- | 58.38%-57.4M | ---- | -45.02%-55.08M | ---- | 43.77%-137.9M | ---- | -56.38%-37.98M |
Special items of earning before tax | -110.36%-9.62M | 9.02%351.12M | -61.27%15.8M | -31.99%1.09B | 1.71%92.79M | -13.88%322.06M | -46.79%40.79M | 129.31%1.6B | 454.70%91.22M | -7.80%373.96M |
Earning before tax | 55.07%8.08B | 82.96%5.56B | 837.97%2.13B | 7,347.34%5.7B | 279.22%5.21B | 50.23%3.04B | 269.73%227.07M | 100.69%76.6M | 111.85%1.37B | -37.43%2.02B |
Tax | -47.70%-1.65B | -63.59%-1.12B | -77.23%-393.61M | -203.82%-2.6B | -39.29%-1.11B | -4.63%-686.04M | 19.32%-222.09M | -35.81%-856.69M | -29.88%-800.49M | 17.40%-655.66M |
After-tax profit from continuing operations | 57.08%6.43B | 88.60%4.44B | 34,722.58%1.74B | 497.58%3.1B | 613.98%4.1B | 72.09%2.35B | 101.22%4.99M | 93.34%-780.09M | 1,675.39%573.73M | -43.95%1.37B |
Earning after tax | 57.08%6.43B | 88.60%4.44B | 34,722.58%1.74B | 497.58%3.1B | 613.98%4.1B | 72.09%2.35B | 101.22%4.99M | 93.34%-780.09M | 1,675.39%573.73M | -43.95%1.37B |
Minority profit | 59.03%2.01B | 179.55%1.2B | 406.76%404.79M | 467.03%1.66B | 763.86%1.26B | 697.50%428.21M | -2,852.59%-131.96M | 82.61%-453.03M | -65.08%-189.94M | -110.90%-71.67M |
Profit attributable to shareholders | 56.22%4.43B | 68.38%3.24B | 872.26%1.33B | 539.90%1.44B | 271.29%2.84B | 33.78%1.93B | 133.09%136.95M | 96.41%-327.06M | 418.19%763.67M | -19.25%1.44B |
Basic earnings per share | 105.59%0.1801 | 112.44%0.1315 | 517.36%0.0505 | 87.51%-0.0115 | 687.92%0.0876 | 62.04%0.0619 | 71.05%-0.0121 | 83.83%-0.0921 | 70.14%-0.0149 | -34.02%0.0382 |
Diluted earnings per share | 105.59%0.1801 | 112.44%0.1315 | 517.36%0.0505 | 87.51%-0.0115 | 687.92%0.0876 | 62.04%0.0619 | 71.05%-0.0121 | 83.83%-0.0921 | 70.14%-0.0149 | -34.02%0.0382 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership), Tianji Hong Kong Certified Public Accountants Limited | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership), Tianji Hong Kong Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data